Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 06, 2023

Efficacy and Safety of Systemic Therapies in Patients With Metastatic Melanoma of Unknown Primary Site

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort
J Am Acad Dermatol 2022 Dec 19;[EPub Ahead of Print], P Rousset, S Dalle, L Mortier, O Dereure, S Dalac, C Dutriaux, MT Leccia, D Legoupil, F Brunet-Possenti, J De Quatrebarbes, JJ Grob, P Saiag, E Maubec, PE Stoebner, F Granel-Brocard, JP Arnault, C Allayous, B Oriano, C Lebbe, H Montaudié

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading